Clinical Trials Browser

Phase 2 × Uveal Melanoma × binimetinib × Clear all

NCT05170334 2025-10-01

Binimetinib Plus Belinostat for Subjects With Metastatic Uveal Melanoma

Phase 2 Active not recruiting

Uveal Melanoma, Eye Neoplasms